Encinitas, CA, United States of America

Scott Alan Wolckenhauer

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 3 CIPO patents. Top assignee: Oppilan Pharma Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott Alan Wolckenhauer. Retrieved from https://idiyas.com/inventor/scott-alan-wolckenhauer-qjhcks7n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scott Alan Wolckenhauer and His Patent Work.

Introduction

Scott Alan Wolckenhauer is an inventor associated with Encinitas, California, United States. His listed patent concerns crystalline forms of a compound investigated as an S1P receptor modulator.

Latest Patents

Wolckenhauer is credited with 1 patent: “Crystalline Forms of an S1P Receptor Modulator.” The patent describes crystalline forms of (R)-5-(2,5-dichloro-4-(5-(8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl)-1,2,4-oxadiazol-3-yl)phenoxy)piperidin-2-one, including a salt or solvate thereof.

Career Highlights

The available information associates Wolckenhauer’s patent work with Oppilan Pharma Ltd. The patent’s focus on crystalline forms reflects research into the physical forms of a pharmaceutical compound.

Collaborations

Jason Harris is identified as a coworker. The available details do not specify the nature of their collaboration or their respective contributions to the patent.

Conclusion

Scott Alan Wolckenhauer’s recorded patent activity centers on crystalline forms of an S1P receptor modulator and is associated with Oppilan Pharma Ltd.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…